地理とフェンタニル:黒人アメリカ人のオピオイド過剰摂取による不均衡な増加を説明する
David Powell1, Dan Han2, Jevay Grooms3
1David Powell (David.Powell@PennMedicine.upenn.edu), University of Pennsylvania, Philadelphia, Pennsylvania.
Health affairs (Project Hope)
|September 2, 2025
まとめ
特にフェンタニル危機の間 オピオイド過剰摂取による死亡において 地理的な差異が大きく影響しています 場所に基づく介入は,これらの過剰摂取の格差を減らすのに役立ちます.
科学分野:
- 公衆衛生
- 流行病学
- 地理学
背景:
- オピオイドの過剰摂取による死亡は 黒人アメリカ人に不釣り合いな影響を及ぼしています
- フェンタニルの拡散はこれらの傾向を悪化させた.
- これらの格差における 地理の役割を理解することは 極めて重要です
研究 の 目的:
- アフリカ系アメリカ人の オピオイド過剰摂取による死亡の増加に 地域的な要因が 与える影響を調査する.
- 過剰摂取率における人種差異に対するフェンタニル危機に対する地理的差異の影響を定量化する.
主な方法:
- 1999年から2020年までの米国の死亡率データ分析.
- 人種,民族,居住地域による年間過剰摂取率のモデル化
- 地理的な発生率と過剰摂取率における人種差の評価
主要な成果:
- 地理的な要因は2013年以前の格差にはほとんど影響しなかったが,フェンタニル危機の際に顕著になった.
- 黒人対白人のオピオイド過剰摂取の増加の約40% (2010-2020年) は,地理的曝露の差によるものです.
- オピオイドとコカインの両方を含むものと比較して,オピオイドのみの過剰摂取では地理がより顕著でした.
結論:
- オピオイド過剰摂取による死亡における 人種差異の主要な要因です
- 地域ベースの介入はこれらの格差を軽減するのに有効です.
- 地域を対象とした公衆衛生戦略に関するさらなる研究が必要である.
関連する概念動画
Opioid Analgesics: Synthetic and Semisynthetic Opioids
421
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
421
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Drug Control Governance: Regulatory Bodies and Their Impact
240
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
240
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655


